News & Updates

Show Multimedia Only

Visual distraction eases pain, anxiety during colonoscopy

02 Oct 2025

Patients undergoing colonoscopy may benefit from visual/audiovisual distraction interventions, which have been shown to reduce pain and anxiety and improve satisfaction during the procedure, suggests a recent study.

Visual distraction eases pain, anxiety during colonoscopy

02 Oct 2025

JAK inhibitor a new hope for new-onset T1D?

02 Oct 2025 by

The 2-year outcomes from the phase II BANDIT* trial confirm the potential of the Janus kinase (JAK) inhibitor baricitinib for the treatment of new-onset type 1 diabetes (T1D).

JAK inhibitor a new hope for new-onset T1D?

02 Oct 2025

Pembrolizumab plus chemo efficacious in advanced PSCC

02 Oct 2025

Treatment with the combination of pembrolizumab plus chemotherapy elicits response in patients with advanced penile squamous cell carcinoma (PSCC) while having a manageable safety profile, according to the phase II HERCULES trial.

Pembrolizumab plus chemo efficacious in advanced PSCC

02 Oct 2025

Awareness rising, yet breast cancer screening rates continue to lag behind

02 Oct 2025 by

Many women in Malaysia are still hesitant to go for regular breast cancer screening despite being aware of its importance.

Awareness rising, yet breast cancer screening rates continue to lag behind

02 Oct 2025

Balancing hope and healing in managing gynaecological tumours in children and adolescents

02 Oct 2025 by

Gynaecological tumours such as ovarian tumours in children and adolescents present complex diagnostic, emotional, and treatment challenges for young patients, families, and healthcare providers.

Balancing hope and healing in managing gynaecological tumours in children and adolescents

02 Oct 2025

Antenatal betamethasone lowers risk of respiratory morbidity in late preterm twin neonates

01 Oct 2025

Antenatal administration of betamethasone in women with twin pregnancies at risk of late preterm delivery appears to reduce the risk of neonatal respiratory morbidity, as shown in a study.

Antenatal betamethasone lowers risk of respiratory morbidity in late preterm twin neonates

01 Oct 2025

Extended risankizumab treatment for CD may be needed in some patients

01 Oct 2025 by

For some patients with Crohn’s disease (CD) who show no response to induction treatment with risankizumab, extending the treatment course is safe and improves clinical and endoscopic outcomes, as shown in a study.

Extended risankizumab treatment for CD may be needed in some patients

01 Oct 2025

Brain fog common in patients with GI disorders

01 Oct 2025

Half of the patients with common gastrointestinal (GI) disorders report experiencing brain fog (BF), reveals a study. BF prevalence is higher in patients on probiotics and those with gastroparesis and irritable bowel syndrome (IBS).